J&J stepping up Tylenol production as coronavirus boosts demand

Johnson & Johnson is running its Tylenol manufacturing at maximum capacity in North America in order to contend with surging demand for the product due to the fast-spreading coronavirus outbreak, the head of its consumer health unit's North American operation said in an interview on Thursday.